XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Cumulative Dividends Declared
Retained Deficit
Accumulated Other Comprehensive Earnings, net of tax
Total
Balance at Dec. 31, 2018 $ 21 $ 211 $ 1,235,108 $ (822,520) $ (326,522) $ 23,877 $ 110,175
Balance (in shares) at Dec. 31, 2018 2,070,678 21,117,006          
Increase (Decrease) in Stockholders' Equity              
Proceeds from exercise of stock options   $ 1 162       163
Proceeds from exercise of stock options (in shares)   64,351          
Stock based compensation     107       107
Other comprehensive (loss) earnings           117 117
Net (loss) earnings         (12,612)   (12,612)
Balance at Mar. 31, 2019 $ 21 $ 212 1,235,377 (822,520) (339,134) 23,994 97,950
Balance (in shares) at Mar. 31, 2019 2,070,678 21,181,357          
Balance at Dec. 31, 2018 $ 21 $ 211 1,235,108 (822,520) (326,522) 23,877 110,175
Balance (in shares) at Dec. 31, 2018 2,070,678 21,117,006          
Increase (Decrease) in Stockholders' Equity              
Net (loss) earnings             (8,739)
Balance at Jun. 30, 2019 $ 21 $ 212 1,235,583 (822,520) (335,261) 24,254 102,289
Balance (in shares) at Jun. 30, 2019 2,070,678 21,181,357          
Balance at Mar. 31, 2019 $ 21 $ 212 1,235,377 (822,520) (339,134) 23,994 97,950
Balance (in shares) at Mar. 31, 2019 2,070,678 21,181,357          
Increase (Decrease) in Stockholders' Equity              
Proceeds from exercise of stock options     206       206
Other comprehensive (loss) earnings           260 260
Net (loss) earnings         3,873   3,873
Balance at Jun. 30, 2019 $ 21 $ 212 1,235,583 (822,520) (335,261) 24,254 102,289
Balance (in shares) at Jun. 30, 2019 2,070,678 21,181,357          
Balance at Dec. 31, 2019 $ 21 $ 212 1,236,237 (822,520) (334,499) 24,786 104,237
Balance (in shares) at Dec. 31, 2019 2,070,678 21,255,426          
Increase (Decrease) in Stockholders' Equity              
Proceeds from exercise of stock options   $ 1 46       47
Proceeds from exercise of stock options (in shares)   9,500          
Stock based compensation     238       238
Other comprehensive (loss) earnings           (3,073) (3,073)
Consolidation of corporate-owned life insurance trusts         (1,281)   (1,281)
Net (loss) earnings         (64,731)   (64,731)
Balance at Mar. 31, 2020 $ 21 $ 213 1,236,521 (822,520) (400,511) 21,713 35,437
Balance (in shares) at Mar. 31, 2020 2,070,678 21,264,926          
Balance at Dec. 31, 2019 $ 21 $ 212 1,236,237 (822,520) (334,499) 24,786 104,237
Balance (in shares) at Dec. 31, 2019 2,070,678 21,255,426          
Increase (Decrease) in Stockholders' Equity              
Consolidation of corporate-owned life insurance trusts         (1,300)    
Net (loss) earnings             (87,560)
Balance at Jun. 30, 2020 $ 21 $ 212 1,236,749 (822,520) (423,340) 23,899 15,021
Balance (in shares) at Jun. 30, 2020 2,070,678 21,229,857          
Balance at Mar. 31, 2020 $ 21 $ 213 1,236,521 (822,520) (400,511) 21,713 35,437
Balance (in shares) at Mar. 31, 2020 2,070,678 21,264,926          
Increase (Decrease) in Stockholders' Equity              
Retirement of restricted stock   $ (1) (125)       (126)
Retirement of restricted stock (in shares)   (35,069)          
Stock based compensation     111       111
Issuance of warrants in connection with debt financing     242       242
Other comprehensive (loss) earnings           2,186 2,186
Net (loss) earnings         (22,829)   (22,829)
Balance at Jun. 30, 2020 $ 21 $ 212 $ 1,236,749 $ (822,520) $ (423,340) $ 23,899 $ 15,021
Balance (in shares) at Jun. 30, 2020 2,070,678 21,229,857